Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results

NEXT STORY
Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update
PREV STORY
California Water Service Group and Subsidiaries Suspend Shutoffs for Customers Unable to Make Payments Amid COVID-19 Pandemic
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aravive Announces Positive Preliminary Data from Phase 1b Trial Evaluating Batiraxcept (AVB-500) in Combination with Cabozantinib for Treatment of Clear Cell Renal Cell Carcinoma

author_avatar
NASDAQ Market News

Virion Therapeutics, LLC Announces the Appointment of M. Michelle Berrey, M.D., M.P.H. and Williamson Bradford, M.D., Ph.D. to Its Board of Directors

author_avatar
NASDAQ Market News

Fibrogen Presents Latest Data From Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at European Respiratory Society (ERS) International Congress 2017

MILAN, Italy, Sept. 13, 2017 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical ...

author_avatar
NASDAQ Market News